...
首页> 外文期刊>BMC Cardiovascular Disorders >N-terminal pro-B-type natriuretic peptide as a prognostic indicator for 30-day mortality following out-of-hospital cardiac arrest: a prospective observational study
【24h】

N-terminal pro-B-type natriuretic peptide as a prognostic indicator for 30-day mortality following out-of-hospital cardiac arrest: a prospective observational study

机译:N-末端Pro-B型利钠肽作为预后指示剂,为30天死亡率后,在医院外心脏骤停后:一个预期的观察性研究

获取原文
           

摘要

Early risk stratification applying cardiac biomarkers may prove useful in sudden cardiac arrest patients. We investigated the prognostic utility of early-on levels of high sensitivity cardiac troponin-T (hs-cTnT), copeptin and N-terminal pro-B-type natriuretic peptide (NT-proBNP) in patients with out-of-hospital cardiac arrest (OHCA). We conducted a prospective observational unicenter study, including patients with OHCA of assumed cardiac origin from the southwestern part of Norway from 2007 until 2010. Blood samples for later measurements were drawn during cardiopulmonary resuscitation or at hospital admission. A total of 114 patients were included, 37 patients with asystole and 77 patients with VF as first recorded heart rhythm. Forty-four patients (38.6%) survived 30-day follow-up. Neither hs-cTnT (p?=?0.49), nor copeptin (p?=?0.39) differed between non-survivors and survivors, whereas NT-proBNP was higher in non-survivors (p? 0.001) and significantly associated with 30-days all-cause mortality in univariate analysis, with a hazard ratio (HR) for patients in the highest compared to the lowest quartile of 4.6 (95% confidence interval (CI), 2.1–10.1), p? 0.001. This association was no longer significant in multivariable analysis applying continuous values, [HR 0.96, (95% CI, 0.64–1.43), p?=?0.84]. Similar results were obtained by dividing the population by survival at hospital admission, excluding non-return of spontaneous circulation (ROSC) patients on scene [HR 0.93 (95% CI, 0.50–1.73), P?=?0.83]. We also noted that NT-proBNP was significantly higher in asystole- as compared to VF-patients, p? 0.001. Early-on levels of hs-cTnT, copeptin and NT-proBNP did not provide independent prognostic information following OHCA. Prediction was unaffected by excluding on-scene non-ROSC patients in the multivariable analysis. ClinicalTrials. gov, NCT02886273 .
机译:应用心脏生物标志物的早期风险分层可能在突发的心脏骤停患者中证明是有用的。我们研究了高敏感性心肌肌钙蛋白-T(HS-CTNT),Copeptin和N-末端Pro-B型利钠肽(NT-ProPNP)的预后效用在医院外心脏骤停的患者中(OHCA)。我们进行了一项预期的观察性未提交研究,包括2007年从挪威西南部的假定心起源的OHCA患者,直到2010年到2010年。在心肺复苏期间或在医院入院期间血液样本进行测量。共有114名患者,37名asystole患者和77例VF患者作为第一个记录心律。四十四名患者(38.6%)幸存了30天的随访。 HS-CTNT(p?= 0.49),也不是椰子(p?= 0.39)不同的非幸存者和幸存者之间的不同,而NT-probnp在非幸存者(p?<0.001)中较高,并且与30显着相关-days在单变量分析中的所有导致死亡率,对于最高四分位数的患者的危险比(HR)(95%置信区间(CI),2.1-10.1),p?<0.001。在多变量分析中,这种关联在施加连续值[hr 0.96,(95%ci,0.64-1.43),p?= 0.84]中,该关联在多变量分析中不再重要。通过将群体除以医院入院的存活率来获得类似的结果,不包括在现场的自发循环(ROSC)患者的不恢复[HR 0.93(95%CI,0.50-1.73),P?= 0.83]。我们还指出,与VF患者相比,NT-probnp在asystole中显着高,p?<0.001。早期的HS-CTNT,Copeptin和NT-probnp的水平没有提供Ohca之后的独立预后信息。在多变量分析中排除现场非ROSC患者,预测不受影响。临床试验。 GOV,NCT02886273。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号